Nxera Pharma Co (TSE:4565) Net Change in Cash : 円-16,797 Mil (TTM As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Nxera Pharma Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Nxera Pharma Co's Net Change in Cash for the three months ended in Dec. 2024 was 円-16,600 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was 円-16,797 Mil.

Nxera Pharma Co Net Change in Cash Historical Data

The historical data trend for Nxera Pharma Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Net Change in Cash Chart

Nxera Pharma Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

24,633.00

20,079.00

6,470.00

-17,492.00

-16,797.00

Nxera Pharma Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Change in Cash	Get a 7-Day Free Trial															6,679.00	-2,550.00	4,469.00	-2,116.00	-16,600.00

Nxera Pharma Co Net Change in Cash Calculation

Nxera Pharma Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-7718	+	-4763	+	-6854	+	2538
	=	-16,797

Nxera Pharma Co's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -10970 + -4944 + -1674 + 988

= -16,600

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-16,797 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nxera Pharma Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Nxera Pharma Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (TSE:4565) » Definitions » Net Change in Cash

Comparable Companies

TSE:4592 TSE:4974 TSE:4894 TSE:219A TSE:4593 TSE:4575 TSE:4599 TSE:7774 TSE:190A TSE:4978 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270

Traded in Other Exchanges

JSS:Germany

Address

Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052

Website

https://www.nxera.life

Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).

Nxera Pharma Co Headlines

No Headlines